Molecular diagnostics, Schemes and Mind Maps of Biotechnology

It's about disease detection and

Typology: Schemes and Mind Maps

2022/2023

Uploaded on 09/14/2023

tarhima-jahan-jerin-1
tarhima-jahan-jerin-1 🇧🇩

2 documents

1 / 22

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
DNA based disease diagnostics system
A disease, in molecular sense, can be defined as any
abnormality in the living system.
The abnormality can be caused due to infection by virus,
bacteria, fungi, parasites, etc.
The abnormality can also arise due to changes in the
molecular structure within the cells.
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff
pf12
pf13
pf14
pf15
pf16

Partial preview of the text

Download Molecular diagnostics and more Schemes and Mind Maps Biotechnology in PDF only on Docsity!

DNA based disease diagnostics system

A disease, in molecular sense, can be defined as any

abnormality in the living system.

The abnormality can be caused due to infection by virus,

bacteria, fungi, parasites, etc.

The abnormality can also arise due to changes in the

molecular structure within the cells.

There are two classes of molecular diagnostic

techniques:

(1)DNA detection methods —which uses nucleic acid

hybridization or the polymerase chain reaction to detect a

specific nucleic acid sequence.

(2) Immunological methods —are based upon the

specificity of an antibody for a particular antigen.

Antibody , also called immunoglobulin, a protective protein produced by

the immune system of an organism in response to the presence of a

foreign substance, called an antigen.

Nucleic acid hybridization:

Hybridization is the process of establishing a non-

covalent , sequence-specific interaction between two or

more complementary strands of nucleic acids into a

single hybrid. There are two types of DNA

hybridization techniques:

a)Radioactive detection system

b) Non-radioactive detection system

PRINCIPLE

Single stranded DNA molecule recognize and specifically bind

to a complementary DNA strand in a mixture of other DNA

strand. This is comparable to a specific key and lock

relationship.

BASIC PROCEDURE:

  • Single stranded target DNA is bound to a membrane support

-DNA probe labeled with detector substance is added

-DNA probe pairs with the complementary target DNA

wash unbound DNA probes

Sequence of nucleotide in the target DNA can be identified

Non-Radioactive detecting system:

Principle:

Detection is based on enzymatic conversion of a

chromogenic (colour producing) or chemiluminescent

(light emitting) substrates. Mainly Biotin-labeled

(Biotinylated) nucleotides are incorporated into DNA

probe.

Advantages : Biotin-labeled DNA is quite stable for

about 1 year.

Chemiluminescence detection is very sensitive than

chromogenic detection system

hybridization:

The disease causing organism can be detected very specifically in

biological samples by nucleic acid hybridization i.e. if the nucleic

acid sequence of a disease causing organism is present in sample,

then it can be hybridized with a nucleic acid probe complementary

to the sequence of this target nucleic acid.

For exmple, The parasite Plasmodium falciparum causes malaria in

man. A specific gene (thereby its product) is the causative agent in

this parasite. A complementary DNA probe to this gene is

synthesized chemically with radiolabelled

32

P. This probe is bonded

to a membrane support. Then the biological sample to be analysed

is added, under appropriate conditions of temperature and ionic

strength to promote base pairing between the probe and the target

avidin-biotin system as a powerful tool in biotechnological sciences. Avidin's affinity

for biotin is exploited in wide-ranging biochemical assays, including the replacement

of radioiodine labeled antibodies in radioimmunoassay systems, to give an assay

system which is not radioactive.

b) Diagnosis of genetic disease using restriction

endonuclease:

Sickle-cell anemia is a genetic disease due to the change in a

single nucleotide in the codon for the sixth amino acid of the

beta-chain of the hemoglobin molecule. Individuals containing

the sickle gene can be screened before the expression of the

symptoms.

The principle for the detection is that, within the beta-globin

gene of a normal individual, there are three sites for the

restriction endonuclease Cvn -1, but in sickle-cell gene one of

these sites is lost due to replacement of the single nucleotide.

In the normal gene, the DNA sequence is CCTG A GG whereas

in the sickle-cell anemia gene, the sequence is CCTG T GG.

d) Detection of mutations at different sites within one gene:

Beta-thalassemia is a genetic disease that is caused due to mutation in

beta-globulin at eight or more sites, thus results in low rate of its synthesis.

Hence instead of detecting each mutation separately all the eight sites are

scanned at the same time.

The amplified target DNA is hybridized to the membrane bound probes

under conditions that allow only perfect matches to hybridize. Then

streptavidin with attached alkaline phosphatase is added, the membrane

washed and a colourless substrate is added.

A coloured spot on the membrane appears wherever there is a perfect

nucleotide match between the amplified target DNA segment and one of

the specific oligoneucleotide probes. Where there is no hybridization

(mutant DNA segments) no colour appears.

Importance of DNA Diagnosis of Genetic Diseases

Traditional laboratory tests for the diagnosis of genetic

diseases are mostly based on the estimation of metabolites

&/or enzymes.

Usually done after the onset of symptoms.

DNA analysis can specifically diagnose the inherited disease at

the genetic level.

DNA based tests are useful to discover, well in advance

whether the individuals or their offsprings are at risk for any

genetic diseases.

Example of some Important genetic diseases for which DNA

analysis is used

CYSTIC FIBROSIS

Common fetal hereditary disease Produce thick and sticky mucus

that clogs lungs and RT.

Defect in CFTR gene that encodes Cystic Fibrosis Transmembrane

Regulator protein located on chromosome 7.

DNA probe has been developed to identify this gene.

Disease developed when 2 recessive genes are present.

Fetal cells obtain from samples of amniotic fluid. It is possible to

know whether the offspring will be victim of CF

Sickle cell anemia :

Occur due to single amino acid change in the β-chain of

hemoglobin. Glutamate at the 6th position of β-chain is

replaced by Valine. This single base mutation can be

detected using restriction enzyme MstII to cut DNA

fragment (RFLP technique) followed by electrophoresis of

DNA fragments. Sickle cell anemia characterized by the

irregular, sickle shape of the erythrocytes. Results in to

anemia

Fragile X syndrome:

Fragile X syndrome due to a genetic defect in X chromosome (a sex

chromosome) affects both males & females. Victims are characterized

by mental retardation.

Have three nucleotide bases ( CGG ) repeated again & again. These

trinucleotide repeats block the transcription process resulting in a

protein deficiency.

This protein is involved in the normal function of the nerve cells, & its

deficiency results in mental retardation. A DNA probe has been

developed for the detection of fragile X syndrome in the laboratory.

P 53 GENE

The gene p53 encodes for a protein with a molecular weight 53

kilodaltons. Thus, p53 is a cancer-suppressor gene and acts as a

guardian of cellular DNA.

GENES OF CANCER

BRCA I and BRCA II function in a manner comparable to gene p

protein. E.g., Gene for melanoma susceptibility, in humans are

located on chromosomes 1 and 9